Bonesupport Holding AB (publ) (STO:BONEX)

Market Cap	21.36B
Revenue (ttm)	1.06B
Net Income (ttm)	147.98M
Shares Out	65.86M
EPS (ttm)	2.22
PE Ratio	146.20
Forward PE	68.66
Dividend	n/a
Ex-Dividend Date	n/a

Volume	127,239
Average Volume	174,041
Open	325.60
Previous Close	323.80
Day's Range	321.80 - 326.80
52-Week Range	244.00 - 405.80
Beta	0.66
RSI	74.79
Earnings Date	Jul 15, 2025

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute t...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1999
• Employees: 139
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BONEX

Financial Performance

In 2024, Bonesupport Holding AB's revenue was 898.73 million, an increase of 52.05% compared to the previous year's 591.08 million. Earnings were 133.75 million, a decrease of -45.41%.